Cite
MLA Citation
E. Juhasz et al.. “3091 Characterization of advanced NSCLC patients with prolonged benefit after veliparib plus carboplatin/paclitaxel: Phase 2 results.” European journal of cancer, vol. 51, n.d., pp. S629–S630. http://access.bl.uk/ark:/81055/vdc_100030628321.0x000005